Ramchandra prasad singh. (Photo | Twitter, @RCP_Singh) 
Odisha

Mission to develop secondary steel sector in the offing: Singh

In an interactive session with representatives of steel companies based in the State, Singh praised the State government and the people of Odisha for taking a lot of strides in development.

Express News Service

BHUBANESWAR: Union Minister of Steel Ram Chandra Prasad Singh on Saturday lauded the role of the State government on skill development.

In an interactive session with representatives of steel companies based in the State, Singh praised the State government and the people of Odisha for taking a lot of strides in development. He said the State government has rightly focused on skill development through institutions like the World Skill Centre, Bhubaneshwar which is the need of the hour.

The Union Minister further said that steel consumption will continue to increase due to the various programmes and schemes of the Central government such as PM Gati Shakti master plan in which the contribution of the secondary steel sector will be very high.

A mission to develop the secondary steel sector is in the making, he said. Ministry officials emphasised that the Centre has been actively taking all efforts to address the concerns of the steel industry and welcomed inputs and comments on specific issues hindering the sector, especially the secondary steel companies.

Concerns of the industry were put forward by representatives from the companies which included a better environment for the industry, especially on finance, logistics, environment and support for the small-scale industries in the sector.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’